It's the kind of news that makes every baseball fan wince. Just when the Miami Marlins finally gave fans what they'd been waiting for, the baseball gods decided to have other plans.
Robby Snelling, one of the most electric pitching prospects in the game, made his long-awaited MLB debut last week. And for five innings, it looked like the start of something special. The left-hander allowed three runs on five hits while striking out two and working around four walks. Not a flawless outing, but a solid one—the kind that shows you exactly why scouts have been buzzing about his arm for years.
The kind of debut that makes you think: the future is here.
But then came the news that no pitcher, no team, and no fan ever wants to hear. The Marlins have placed Snelling on the Injured List with a sprained UCL. For those keeping score at home, that's the same ligament that so often leads to Tommy John surgery and a long road back.
It's a heartbreaking turn for a player who had been absolutely unstoppable. At Triple-A this season, Snelling posted a staggering 1.88 ERA and 0.90 WHIP over 29 innings, striking out 44 batters. Last year? A 1.27 ERA with 81 strikeouts in 63.2 innings. He didn't just knock on the big-league door—he kicked it down.
The Marlins had no choice but to call him up. And now, they have no choice but to be patient.
Right now, it's unclear whether Snelling will need surgery or if rest and rehab can do the trick. But in the worst-case scenario—and we've all been conditioned to think that way—he could miss the rest of this season and most of 2027. That's a tough pill to swallow for a franchise that has been building its future around arms just like his.
The good news? Miami has depth. Braxton Garrett, who missed all of 2025 recovering from his own UCL surgery, is healthy and dealing at Triple-A with a 2.30 ERA and 0.80 WHIP. He's ready to step in and keep the rotation afloat while Snelling focuses on getting right.
For now, all we can do is wait, hope, and remember that the best pitchers are worth the wait. Snelling's future is still incredibly bright—it's just going to take a little longer to get there.